According to FDA-approved labeling, use of dabigatran and edoxaban for acute VTE treatment requires 5 to 10 days of parenteral anticoagulation.
Emily M. Hawes, PharmD, BCPS, CPP
Advertisement
Articles by Emily M. Hawes, PharmD, BCPS, CPP
Two new medications have recently been approved to help patients lose weight: lorcaserin and phentermine and topiramate extended-release.
Advertisement
Latest Updated Articles
- Chronic Weight Management: New Medications
May 20th 2013
Advertisement
Advertisement
Trending on Pharmacy Times
1
Functional Cure of Hepatitis B Infections Among Patients Coinfected With HIV
2
Why Stanford, Harvard, and Yale Are Betting on Psychedelics
3
FDA Expands Casgevy Approval to Children as Young as 2 Years With Sickle Cell Disease or Transfusion-Dependent β-Thalassemia
4
Sustainable GLP-1 Coverage Requires Balancing Access, Cost, and Long-Term Value
5